Use of M-CSF antibodies in the treatment of osteoarthritis or pain

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9243066
APP PUB NO 20140205608A1
SERIAL NO

14126878

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates generally to a method for the treatment and/or prophylaxis of osteoarthritis (OA) and/or pain. In accordance with the present invention, an antagonist of c-Fms is effective in the treatment of osteoarthritis and/or pain. An antagonist of M-CSF includes, but is not limited to, an antibody that is specific for M-CSF, IL-34 or c-Fms.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MORPHOSYS AG82152 PLANEGG

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cook, Andrew David North Melbourne, AU 15 84
Hamilton, John Allan Aberfeldie, AU 14 22
Steidl, Stefan Munich, DE 31 94

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 26, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00